Delivery Order SPE2DB22D2211-SPE2DB24FMNW0
Award Date 1/10/24
Potential Completion Date 2/1/24
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,609,982 units of the pharmaceutical product XEOMIN 100 Unit Vials. The contract has a potential value of $7,715.88 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,271,898 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The potential value of this contract is $7,863.60 and the period of performance extends through January 29, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,290.88 firm fixed price delivery order for 4,563,609,979 units of XEOMIN 100 unit vials. This award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, valued at $3,669.68 for the supply of 4,563,451,766 units of XEOMIN 100 unit vials. The delivery order is set to be completed by February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceutical products and medical supplies to the Department of Defense through an Indefinite Delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,240,411 units of the drug XEOMIN 100 UNIT VIALS. The $5,242.40 contract has a performance period through May 1, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, is the sole awardee on this delivery order, which is issued under a larger...
- The Defense Logistics Agency (DLA) awarded a $10,485.00 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,496,211 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical...
- The Defense Logistics Agency (DLA) has awarded a $20,970.00 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of 4,563,759,737 units of the drug XEOMIN. This delivery order is not associated with any set-aside program and has a completion date of March 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $24,639.28 firm-fixed-price contract is for the supply of 4,565,970,488 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The order has an ultimate completion date of October 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
- The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,242,270 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The $3,145.44 delivery order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received multiple Federal contract awards from the Defense Logistics Agency to supply pharmaceuticals, medical supplies, and related...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,687.50 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4,565,833,076 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. This delivery order has an ultimate completion date of October 4, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities to federal agencies. This award appears to be part of a larger Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMNW0Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,301,682 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The $6,667.40 contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor to the DLA, providing a range of pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen's parent company is Cencora, Inc., which also does business as Amerisourcebergen. No set-aside designation was used for this award.
Generated 4/10/24, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 1/10/24 |